EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...

The latest announcement is out from Novavax ( (NVAX) ).

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...

The Cha Vaccine Institute has vowed to focus on developing pipelines with high chances of commercialization and bolstering ...

PW Consulting has released a comprehensive research report on the SP Sepharose HP Market, offering valuable insights for investors, industry professionals, and stakeholders. As the market for ...

The Acute Ischemic Stroke pipeline presents opportunities with 25+ drugs in development across various stages, emphasizing innovative treatments like Prourokinase recombinant, RNS60, and AVLX-144. Key ...